Affimed N.V. (Nasdaq: AFMD), reported financial results for the quarter ended June 30, 2015. Over this past quarter we have presented exciting data that demonstrates the potential of our unique NK-cell engaging approach, in particular preclinical data showing that our lead program AFM13 has therapeutic synergy in combination with checkpoint inhibitors,” said Dr. Adi Hoess, CEO of Affimed. “The recent follow-on financing further supports our commitment to making a significant impact with our TandAbs on the evolving immune- oncology landscape, which is why we are expanding and optimizing our clinical programs. Affimed N.V. (NASDAQ:AFMD) belongs to Healthcare sector. Its weekly performance is -11.17%. On last trading day company shares ended up $14.23. Affimed N.V. (NASDAQ:AFMD) distance from 50-day simple moving average (SMA50) is -0.11%.
Magnum Hunter Resources Corp (NYSE:MHR) will be releasing its Q215 earnings data on Friday, August 7th. Analysts expect Magnum Hunter Resources Corp to post earnings of ($0.38) per share and revenue of $64.98 million for the quarter. Magnum Hunter Resources Corp. (NYSE:MHR) shares advanced 10.81% in last trading session and ended the day at $0.82. MHR Gross Margin is 80.90% and its return on assets is -20.20%. Magnum Hunter Resources Corp. (NYSE:MHR) quarterly performance is -56.61%.
Amid sliding oil prices and plunging profits, Chevron faces a “difficult” road to sustainability, one energy analyst said Monday.U.S. crude continued its slide Monday, falling more than 4 percent to bring losses to about 22 percent this year. Chevron has taken a beating from the commodity’s movement, as the company’s second-quarter profit reported Friday plummeted about 90 percent year-over-year to $571 million. On 06 August, Chevron Corporation (NYSE:CVX) shares advanced 1.38% and was closed at $85.19. CVX EPS growth in last 5 year was 14.10%. Chevron Corporation (NYSE:CVX) year to date (YTD) performance is -22.55%.
CAS Medical Systems Inc. (NASDAQ:CASM), financial results for the three and six months ended June 30, 2015. Net sales were $5.8 million for the second quarters of both 2015 and 2014. The net loss applicable to common stockholders for the second quarter of 2015 was $2.3 million, or $0.09 per common share, compared with a net loss applicable to common stockholders of $2.6 million, or $0.13 per common share, for the second quarter of 2014. CAS Medical Systems Inc. (NASDAQ:CASM) ended the last trading day at $1.10. Company weekly volatility is calculated as 10.76% and price to cash ratio as 2.65. CAS Medical Systems Inc. (NASDAQ:CASM) showed a weekly performance of 2.80%.
Energizer Holdings, Inc. (NYSE: ENR) announced results for the third fiscal quarter, which ended June 30, 2015. Third quarter results were in-line with expectations as organic revenue growth exceeded category value performance,” said Alan Hoskins, CEO. “Excluding unfavorable currency impacts, our gross margin continued to benefit from our ongoing cost saving initiatives and favorable commodity costs. During the quarter, we continued to increase support of our leading global brands, including our recently launched EcoAdvanced, the world’s first battery made from recycled batteries. Our colleagues did an outstanding job preparing the organization for completion of the spin while focusing on advancing the business, and I am confident in our ability to continue successfully executing on our strategy. Energizer Holdings, Inc. (NYSE:ENR) shares advanced 4.28% in last trading session and ended the day at $41.14. ENR Gross Margin is 47.20% and its return on assets is 19.40%.